US 8911722
Modulation of yeast-based immunotherapy products and responses
granted A61KA61K2039/505A61K2039/523
Quick answer
US patent 8911722 (Modulation of yeast-based immunotherapy products and responses) held by The Regents of the University of Colorado, a Body Corporate expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K2039/523, A61K2039/57, A61K36/06